Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNexxen Int Ltd Regulatory News (NEXN)

Share Price Information for Nexxen Int Ltd (NEXN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 249.50
Bid: 248.00
Ask: 249.50
Change: 1.00 (0.40%)
Spread: 1.50 (0.605%)
Open: 253.50
High: 255.00
Low: 247.00
Prev. Close: 248.50
NEXN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q4 2023 Results Conference Call Details

27 Feb 2024 07:00

RNS Number : 5214E
Nexxen International Ltd
27 February 2024
 

27 February 2024

Nexxen International Ltd

("Nexxen" or the "Company")

 

Nexxen to Announce Fourth Quarter 2023 Financial Results on March 6, 2024

 

Conference call and webcast to be held March 6, 2024, at 9:00 AM ET / 2:00 PM GMT

 

Nexxen International Ltd. (AIM/NASDAQ: NEXN) ("Nexxen" or the "Company"), a global, unified advertising technology platform with deep expertise in video and Connected TV ("CTV"), will release its financial results for the fourth quarter and twelve months ended December 31, 2023 before the U.S. market opens on Wednesday, March 6, 2024.

 

The Company will host a webcast and conference call at 6:00 AM PT / 9:00 AM ET / 2:00 PM GMT on the same date to discuss its financial results and outlook.

 

Webcast and Conference Call Details

 

· Nexxen International Fourth Quarter and Twelve Months Ended December 31, 2023 Earnings Webcast and Conference Call

· March 6, 2024, at 6:00 AM PT / 9:00 AM ET / 2:00 PM GMT

· Webcast Link: https://edge.media-server.com/mmc/p/93my32xz

· Participant Dial-In Numbers:

U.S. / Canada Participant Toll-Free Dial-In Number: (888) 596-4144

U.K. Participant Toll-Free Dial-In Number: +44 800 260 6470

International Participant Toll-Free Dial-In Number: (646) 968-2525

Conference ID: 5462475

 

About Nexxen

 

Nexxen empowers advertisers, agencies, publishers and broadcasters around the world to utilize video and Connected TV in the ways that are most meaningful to them. Comprised of a demand-side platform (DSP), supply-side platform (SSP), ad server and data management platform (DMP), Nexxen delivers a flexible and unified technology stack with advanced and exclusive data at its core. Our robust capabilities span discovery, planning, activation, measurement and optimization - available individually or in combination - all designed to enable our partners to reach their goals, no matter how far-reaching or hyper niche they may be. For more information, visit nexxen.com.

 

Nexxen is headquartered in Israel and maintains offices throughout the United States, Canada, Europe and Asia-Pacific, and is traded on the London Stock Exchange (AIM: NEXN) and NASDAQ (NEXN).

 

For further information please contact:

 

Nexxen International Ltd.Billy Eckert, Vice President of Investor Relations

ir@nexxen.com

Caroline Smith, Vice President of Communications csmith@nexxen.com

KCSA (U.S. Investor Relations)David Hanover, Investor Relations nexxenir@kcsa.com

 

Vigo Consulting (U.K. Financial PR & Investor Relations)Jeremy Garcia / Peter Jacob / Aisling FitzgeraldTel: +44 20 7390 0230 or nexxen@vigoconsulting.com

 

Cavendish Capital Markets Limited

Jonny Franklin-Adams / Charlie Beeson / George Dollemore (Corporate Finance)Tim Redfern / Harriet Ward (ECM)Tel: +44 20 7220 0500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOREAEAKADPLEAA
Date   Source Headline
5th Feb 20247:00 amRNSShare buyback-transaction in own shares
1st Feb 20247:00 amRNSShare buyback-transaction in own shares
31st Jan 20247:00 amRNSShare buyback-transaction in own shares
30th Jan 20247:00 amRNSShare buyback-transaction in own shares
29th Jan 202411:10 amRNSDirector Dealings
29th Jan 20247:00 amRNSShare buyback-transaction in own shares
26th Jan 20247:00 amRNSShare buyback-transaction in own shares
25th Jan 20247:00 amRNSShare buyback-transaction in own shares
24th Jan 20247:00 amRNSShare buyback-transaction in own shares
23rd Jan 20247:00 amRNSShare buyback-transaction in own shares
22nd Jan 20247:00 amRNSShare buyback-transaction in own shares
19th Jan 20247:00 amRNSShare buyback-transaction in own shares
18th Jan 20247:00 amRNSShare buyback-transaction in own shares
17th Jan 20247:01 amRNSShare buyback-transaction in own shares
17th Jan 20247:00 amRNSBoard Appointments
16th Jan 20247:00 amRNSShare buyback-transaction in own shares
15th Jan 20249:53 amRNSBlock Listing Six Monthly Return
15th Jan 20247:00 amRNSShare buyback-transaction in own shares
12th Jan 20247:00 amRNSShare buyback-transaction in own shares
11th Jan 202412:30 pmRNSNexxen to Present at the Needham Growth Conference
11th Jan 20247:00 amRNSShare buyback-transaction in own shares
10th Jan 202412:55 pmRNSDirector Dealings
10th Jan 20247:00 amRNSShare buyback-transaction in own shares
11th Dec 20094:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.